Fredrikson & Byron acted as legal counsel to Celcuity Inc. (NASDAQ: CELC) in its initial public offering of 2.76 million shares of common stock with total gross proceeds of $26.2 million, before underwriting discounts and offering expenses. The shares of common stock began trading September 20, 2017. Celcuity is a functional cellular analysis company that is discovering new cancer subtypes and commercializing diagnostic tests designed to significantly improve clinical outcomes of cancer patients treated with targeted therapies.
Fredrikson’s legal team was led by Eric Madson, Ryan Brauer and Joseph Schauer.
Read the news release.
